Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT

View source ↗

Summary

The IMPACT trial evaluating the effect of antimalarials, including hydroxychloroquine, on COVID-19 infections has completed in patients with rheumatoid arthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Alberta | Conditions: Covid-19 Infection, Rheumatoid Arthritis | Status: COMPLETED